Soligenix Advances Novel Therapy for Hard-to-Diagnose Skin Cancer CTCL
January 14, 2026 — Soligenix develops HyBryte™ therapy for CTCL, a rare skin cancer notoriously difficult to diagnose early. Learn about this novel treatment approach for cutaneous T-cell lymphoma.